Skip to search formSkip to main contentSkip to account menu

Fibrates, lipid modifying drugs, plain

Known as: Fibrates 
National Institutes of Health

Related topics

Related topics

1 relation
Fibrates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Role of fibrates in reducing coronary risk: a UK Consensus.
This paper presents the consensus reached by a panel of experts on the role of fibrates in reducing coronary heart disease (CHD… 
2004
2004
PPARα-dependent modulation of hepatic CYP1A by clofibric acid in rats
Fibrates, hypolipidemic drugs, have been reported to suppress the metabolic activities of cytochrome P450 1A1 and 1A2 in rats but… 
2004
2004
Influence of lipid lowering fibrates on P-glycoprotein activity in vitro.
2003
2003
Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis
Rhabdomyolysis is a severe adverse effect of hypolipidaemic agents such as statins and fibrates. We evaluated this muscular… 
Highly Cited
2001
Highly Cited
2001
Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates.
Highly Cited
1997
Highly Cited
1997
Role of PPAR in the Pharmacological Regulation of Lipoprotein Metabolism by Fibrates and Thiazolidinediones
The peroxisome proliferator activated receptors or PPARs constitute a subfamily of the nuclear hormone receptor superfamily of… 
1997
1997
Studies on the mechanism of fibrate-inhibited expression of plasminogen activator inhibitor-1 in cultured hepatocytes from cynomolgus monkey.
Fibrates are widely used drugs in hyperlipidemic disorders. In addition to lowering serum triglyceride levels, fibrates have also… 
1996
1996
Decreased susceptibility to copper‐induced oxidation of rat‐lipoproteins after fibrate treatment: influence of fatty acid composition
1 The effect of clofibrate (CFB), bezafibrate (BFB), and gemfibrozil (GFB) on plasma lipoprotein (VLDL and LDL) concentration… 
Review
1992
Review
1992
Mode of action of fibrates.
1991
1991
[Side effects of fibrates (except liver and muscle)].
If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)